about
Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanismsPhytochemicals for the Management of MelanomaRole of Apaf-1, a key regulator of apoptosis, in melanoma progression and chemoresistanceBurden of illness for metastatic melanoma in Canada, 2011-2013Methylation and loss of Secreted Frizzled-Related Protein 3 enhances melanoma cell migration and invasionGLI2-mediated melanoma invasion and metastasis.Evidence of ultraviolet type mutations in xeroderma pigmentosum melanomas.Libraries enriched for alternatively spliced exons reveal splicing patterns in melanocytes and melanomas.Association between non-melanoma and melanoma skin cancer rates, vitamin D and latitude.The regulation of miRNA-211 expression and its role in melanoma cell invasiveness.Cytoplasmic Skp2 expression is increased in human melanoma and correlated with patient survivalEpigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategiesThe Role of B-RAF Mutations in Melanoma and the Induction of EMT via Dysregulation of the NF-κB/Snail/RKIP/PTEN CircuitAberrant DNA methylation in malignant melanomaIs oestrogen an important player in melanoma progression?Nicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanomaA new understanding in the epidemiology of melanomaMelanocyte transformation associated with substrate adhesion impediment.The leukemia inhibitory factor (LIF) and p21 mediate the TGFβ tumor suppressive effects in human cutaneous melanomaChronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model.A novel histochemical method for a simultaneous staining of melanin and collagen fibersStage-specific prognostic biomarkers in melanomaUV wavelength-dependent DNA damage and human non-melanoma and melanoma skin cancer.Novel biomarkers and therapeutic targets for optimizing the therapeutic management of melanomasEpigenetic reprogramming as a key contributor to melanocyte malignant transformation.Loss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor prognosis.Epigenetic events in malignant melanoma.Effects of T-cadherin expression on B16F10 melanoma cellsThe Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer MetastasisGenome-wide methylated CpG island profiles of melanoma cells reveal a melanoma coregulation networkGenome-wide screen of promoter methylation identifies novel markers in melanoma.Epigenetics and dermatological disease.Reduced Apaf-1 expression in human cutaneous melanomasA t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasionThe epigenetic reprogramming of poorly aggressive melanoma cells by a metastatic microenvironment.Hedgehog signaling in skin cancersEpigenetic regulation of miRNA genes and their role in human melanomas.Adoptive T-cell transfer in melanoma.Ret transgenic mouse model of spontaneous skin melanoma: focus on regulatory T cells.Targeting MAPK pathway in melanoma therapy.
P2860
Q24676404-FDE64322-329F-429A-B49D-7644722D23F9Q26766708-D6C61F0C-0C13-4C63-A9A3-A914726B7E57Q28277703-66241757-AB0E-46F7-A6AA-EA5D6E80411CQ28354125-364ADC9F-A6C1-4611-B9BF-7084890E6E63Q28741295-FBB91B10-18E1-438C-B490-9B025B577722Q30431168-5D9AE7EB-A8D6-4525-98D6-2D6866E53CF7Q30487052-3C4B65FD-58C6-4ED9-ACC5-972888CD2B1FQ30780305-E748231D-2771-4F56-9BD6-65AA8B24F91BQ33684780-DF79C9D4-8FBD-4C3B-8D27-46778AEB0F63Q33745034-C0952438-EFDB-4BE9-8BC3-6FBCF6F9A505Q33840856-19B10AA7-242C-46C9-A92F-5886DD153546Q33980682-FBC98645-11A7-48A4-905A-3B55BBD55D0FQ34106285-A0459DFC-DCBB-430C-905E-4ECCA28AAB2DQ34516587-CE4240C6-636F-491A-A980-62B4623C5984Q34589095-AD035781-C7AC-4F22-8D98-2FAB9D3DBA37Q34603154-C2F917F0-F25F-4060-9CD2-F461AFAE98B7Q34625205-5B1DA31F-F538-45FE-8989-8CA39A2EC97AQ35052171-365C59C3-03E8-4890-A0D5-380936E55D3CQ35318953-111C4AEA-1994-47C5-BF90-25CB3E40A0DEQ35345202-38CA9829-B9F7-4757-ACFF-9CCF29C89480Q35440883-D8710408-4C16-4586-8380-F8860A2D2B1EQ35551970-DDE172CF-F9C8-44A4-9A67-597EAFF38788Q35787900-52E10106-C7A8-4C97-B0F5-D07C2B7ED00DQ35845352-26E35360-42EB-4EF0-90C6-5DEB46BE829AQ35985447-3D4A88B1-BC38-4CE1-B740-34866A805E43Q36356155-ECC834C4-5152-4BDD-BC02-6E48F44B94D4Q36764224-69451880-80F7-48A1-9C67-09303B92165EQ36774517-C03D1796-5B6F-42B7-8F0F-53C509110ECBQ36985643-87C5F03F-DBBF-470A-9B07-3D51B8780200Q37231658-B0E15F75-DA09-46ED-85CD-537C06DC8E33Q37287368-5565B6F5-7204-4F15-A5EC-B115412B768DQ37346201-93B4F185-EDDF-4D23-AA6E-A47D11398457Q37355450-A81ED951-A080-48D7-9D34-DE350494F17CQ37429052-EB5695B8-E8B1-4322-B840-3D51F4522F83Q37600270-185E1F22-CFCA-4FFB-AE3B-F256F15C7694Q37852292-B7A5AE0D-3CAE-4C7E-AA50-121F4D432B5EQ37983892-136404BB-7F23-4465-87CE-DBB608D53164Q38068968-3CB46E5C-511D-46E9-B18A-A1FB9D2D8276Q38096466-D84D15A8-C47B-4582-A53D-A14C51FFFDFBQ38098888-ECA77A64-6E01-4592-8DBA-F98742B0EEE0
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Focus on melanoma.
@ast
Focus on melanoma.
@en
Focus on melanoma.
@nl
type
label
Focus on melanoma.
@ast
Focus on melanoma.
@en
Focus on melanoma.
@nl
prefLabel
Focus on melanoma.
@ast
Focus on melanoma.
@en
Focus on melanoma.
@nl
P1433
P1476
Focus on melanoma.
@en
P2093
Alan N Houghton
David Polsky
P304
P356
10.1016/S1535-6108(02)00161-7
P577
2002-10-01T00:00:00Z